Cargando…

IgG in cervicovaginal mucus traps HSV and prevents vaginal Herpes infections

IgG is the predominant immunoglobulin in cervicovaginal mucus (CVM), yet how IgG in mucus can protect against infections is not fully understood. IgG diffuses rapidly through cervical mucus, slowed only slightly by transient adhesive interactions with mucins. We hypothesize this almost unhindered di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ying-Ying, Kannan, Arthi, Nunn, Kenetta L., Murphy, Michael A., Subramani, Durai B., Moench, Thomas, Cone, Richard, Lai, Samuel K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122653/ https://www.ncbi.nlm.nih.gov/pubmed/24496316 http://dx.doi.org/10.1038/mi.2013.120

Ejemplares similares

Herpes simplex virus binding IgG traps HSV in human cervicovaginal mucus across the menstrual cycle and diverse vaginal microbial composition
por: Schroeder, Holly A., et al.
Publicado: (2018)

Enhanced Trapping of HIV-1 by Human Cervicovaginal Mucus Is Associated with Lactobacillus crispatus-Dominant Microbiota
por: Nunn, Kenetta L., et al.
Publicado: (2015)

Diffusion of Immunoglobulin G in Shed Vaginal Epithelial Cells and in Cell-Free Regions of Human Cervicovaginal Mucus
por: Wang, Ying-Ying, et al.
Publicado: (2016)

Pretreatment of Human Cervicovaginal Mucus with Pluronic F127 Enhances Nanoparticle Penetration without Compromising Mucus Barrier Properties to Herpes Simplex Virus
por: Ensign, Laura M., et al.
Publicado: (2014)

The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis
por: Hoang, Thuy, et al.
Publicado: (2020)

Cervicovaginal fluid and semen block the microbicidal activity of hydrogen peroxide produced by vaginal lactobacilli
por: O'Hanlon, Deirdre E, et al.
Publicado: (2010)

The Cervicovaginal Mucus Barrier
por: Lacroix, Guillaume, et al.
Publicado: (2020)

Cervicovaginal mucus barrier properties during pregnancy are impacted by the vaginal microbiome
por: Zierden, Hannah C., et al.
Publicado: (2023)

Unraveling the Dynamics of the Human Vaginal Microbiome
por: Nunn, Kenetta L., et al.
Publicado: (2016)

Effect of Genital Herpes on Cervicovaginal HIV Shedding in Women Co-Infected with HIV AND HSV-2 in Tanzania
por: Todd, Jim, et al.
Publicado: (2013)

Anti-HIV-1 Activity of Lactic Acid in Human Cervicovaginal Fluid
por: Tyssen, David, et al.
Publicado: (2018)

Differential Binding of IgG and IgA to Mucus of the Female Reproductive Tract
por: Fahrbach, Kelly M., et al.
Publicado: (2013)

Altering Mucus Rheology to “Solidify” Human Mucus at the Nanoscale
por: Lai, Samuel K., et al.
Publicado: (2009)

Human cervicovaginal mucus contains an activity that hinders HIV-1 movement
por: Shukair, Shetha A., et al.
Publicado: (2012)

Mutual Preservation: A Review of Interactions Between Cervicovaginal Mucus and Microbiota
por: Vagios, Stylianos, et al.
Publicado: (2021)

Pan-HSV-2 IgG Antibody in Vaccinated Mice and Guinea Pigs Correlates with Protection against Herpes Simplex Virus 2
por: Halford, William P., et al.
Publicado: (2013)

Germicidal Powers of Vaginal Mucus
Publicado: (1907)

Prevalence of HAV Ab, HEV (IgG), HSV2 IgG, and Syphilis Among Sheltered Homeless Adults in Tehran, 2012
por: Jahanbakhsh, Fatemeh, et al.
Publicado: (2017)

Urea dilution of serum for reproducible anti-HSV1 IgG avidity index
por: Olsson, Jan, et al.
Publicado: (2019)

Association of HPV infection and clearance with cervicovaginal immunology and the vaginal microbiota
por: Shannon, B, et al.
Publicado: (2017)

Vaginal pH and Microbicidal Lactic Acid When Lactobacilli Dominate the Microbiota
por: O’Hanlon, Deirdre E., et al.
Publicado: (2013)

Changes in the Vaginal Microbiome during the Pregnancy to Postpartum Transition
por: Nunn, Kenetta L., et al.
Publicado: (2021)

Assessment of IgG Antibodies Against HSV1, HSV2, CMV and EBV in Patients with Pemphigus Vulgaris Versus Healthy People
por: Ghalayani, Parichehr, et al.
Publicado: (2015)

Modeling of Virion Collisions in Cervicovaginal Mucus Reveals Limits on Agglutination as the Protective Mechanism of Secretory Immunoglobulin A
por: Chen, Alex, et al.
Publicado: (2015)

In vaginal fluid, bacteria associated with bacterial vaginosis can be suppressed with lactic acid but not hydrogen peroxide
por: O'Hanlon, Deirdre E, et al.
Publicado: (2011)

Genital herpes evaluation by quantitative TaqMan PCR: correlating single detection and quantity of HSV-2 DNA in cervicovaginal lavage fluids with cross-sectional and longitudinal clinical data
por: Aumakhan, Bulbulgul, et al.
Publicado: (2010)

Involvement of STAT4 in IgG subtype switching and ocular HSV-1 replication in mice
por: Allen, Sariah J., et al.
Publicado: (2010)

Evaluation of HSV-2 gE Binding to IgG-Fc and Application for Vaccine Development
por: Galli, Jennifer D., et al.
Publicado: (2022)

Microbicide excipients can greatly increase susceptibility to genital herpes transmission in the mouse
por: Moench, Thomas R, et al.
Publicado: (2010)

Vaginal concentrations of lactic acid potently inactivate HIV
por: Aldunate, Muriel, et al.
Publicado: (2013)

Hexavalent sperm-binding IgG antibody released from vaginal film for development of potent on-demand nonhormonal female contraception
por: Shrestha, Bhawana, et al.
Publicado: (2021)

Relation between FCGRIIB rs1050501 and HSV-1 specific IgG antibodies in Alzheimer’s disease
por: Costa, Andrea Saul, et al.
Publicado: (2020)

Probiotics Reduce Vaginal Candidiasis in Pregnant Women via Modulating Abundance of Candida and Lactobacillus in Vaginal and Cervicovaginal Regions
por: Ang, Xin Yee, et al.
Publicado: (2022)

Recurrence of herpes zoster in a young woman with IgG3 deficiency
por: Yang, Ki-Hwan, et al.
Publicado: (2015)

The antiviral activity of arbidol hydrochloride against herpes simplex virus type II (HSV-2) in a mouse model of vaginitis
por: Du, Qiuling, et al.
Publicado: (2019)

Vaginal microbicides: detecting toxicities in vivo that paradoxically increase pathogen transmission
por: Cone, Richard A, et al.
Publicado: (2006)

The Interplay Between Cervicovaginal Microbial Dysbiosis and Cervicovaginal Immunity
por: Wang, Ya, et al.
Publicado: (2022)

Vaginal mass: a rare manifestation of IgG4-related disease
por: Rujiwetpongstorn, Rujira, et al.
Publicado: (2022)

Influence of dapivirine vaginal ring use on cervicovaginal immunity and functional microbiome in adolescent girls
por: Farr Zuend, Christina, et al.
Publicado: (2021)

Protease activities of vaginal Porphyromonas species disrupt coagulation and extracellular matrix in the cervicovaginal niche
por: Lithgow, Karen V., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vdm63spe2d8gfspied6rtqusgc